Juan Serna1,2, Ruchika Talwar3,4,5, Daniel J Lee3,4,5. 1. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. sernajuanse@gmail.com. 2. Jordan Medical Education Center, 6th Floor, 3400 Civic Center Blvd., Building 421, Philadelphia, PA, 19104, USA. sernajuanse@gmail.com. 3. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. 4. Division of Urology, Department of Surgery, Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 5. Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
Abstract
PURPOSE OF REVIEW: Surgeons have played a significant role in the current opioid epidemic through overprescribing practices in the postoperative setting. However, contemporary efforts have helped to decrease opioid excess, particularly in the field of urology. Minimally invasive surgery offers a unique avenue to address overuse of narcotics in the postoperative period given its emphasis on enhanced recovery. RECENT FINDINGS: Historically, the majority of the literature characterizing postoperative opioid use and its reduction has focused on non-urological surgery. However, recent studies have shown that patients undergoing urologic procedures are prescribed opioids in a similar manner as patients in other surgical specialties. Reduction strategies have been implemented through the use of regional anesthesia, enhanced recovery after surgery pathways, and the development of procedure-specific opioid prescription recommendations. Patients undergoing urologic surgery experience the same risk of opioid misuse and abuse as patients undergoing other types of surgery. However, the wide use of minimally invasive urological surgeries including robotic surgery offers a unique opportunity to reduce postoperative opioid use through multimodal and interdisciplinary protocols and standardizing guidelines.
PURPOSE OF REVIEW: Surgeons have played a significant role in the current opioid epidemic through overprescribing practices in the postoperative setting. However, contemporary efforts have helped to decrease opioid excess, particularly in the field of urology. Minimally invasive surgery offers a unique avenue to address overuse of narcotics in the postoperative period given its emphasis on enhanced recovery. RECENT FINDINGS: Historically, the majority of the literature characterizing postoperative opioid use and its reduction has focused on non-urological surgery. However, recent studies have shown that patients undergoing urologic procedures are prescribed opioids in a similar manner as patients in other surgical specialties. Reduction strategies have been implemented through the use of regional anesthesia, enhanced recovery after surgery pathways, and the development of procedure-specific opioid prescription recommendations. Patients undergoing urologic surgery experience the same risk of opioid misuse and abuse as patients undergoing other types of surgery. However, the wide use of minimally invasive urological surgeries including robotic surgery offers a unique opportunity to reduce postoperative opioid use through multimodal and interdisciplinary protocols and standardizing guidelines.
Entities:
Keywords:
Endourology; Narcotics; Opioids; Postoperative pain; Robotic surgery
Authors: Chad M Brummett; Jennifer F Waljee; Jenna Goesling; Stephanie Moser; Paul Lin; Michael J Englesbe; Amy S B Bohnert; Sachin Kheterpal; Brahmajee K Nallamothu Journal: JAMA Surg Date: 2017-06-21 Impact factor: 14.766
Authors: Richard C Dart; Hilary L Surratt; Theodore J Cicero; Mark W Parrino; S Geoff Severtson; Becki Bucher-Bartelson; Jody L Green Journal: N Engl J Med Date: 2015-01-15 Impact factor: 91.245
Authors: Kevin Koo; Farzana Faisal; Natasha Gupta; Alexa R Meyer; Hiten D Patel; Phillip M Pierorazio; Brian R Matlaga Journal: J Urol Date: 2019-08-29 Impact factor: 7.450
Authors: Matthew J Ziegelmann; Jason P Joseph; Amy E Glasgow; Mark D Tyson; Raymond W Pak; Halena M Gazelka; Ashton L Schatz; Bradley C Leibovich; Elizabeth B Habermann; Matthew T Gettman Journal: Mayo Clin Proc Date: 2019-02 Impact factor: 7.616
Authors: Giovanni Enrico Cacciamani; Nicola Menestrina; Marco Pirozzi; Alessandro Tafuri; Paolo Corsi; Davide De Marchi; Davide Inverardi; Tania Processali; Nicolo' Trabacchin; Mario De Michele; Marco Sebben; Maria Angela Cerruto; Vincenzo De Marco; Filippo Migliorini; Antonio Benito Porcaro; Walter Artibani Journal: J Endourol Date: 2019-01-31 Impact factor: 2.942
Authors: Hiten D Patel; Arnav Srivastava; Neil D Patel; Farzana A Faisal; Wesley Ludwig; Gregory A Joice; Zeyad R Schwen; Mohamad E Allaf; Misop Han; Amin S Herati Journal: Eur Urol Date: 2018-10-21 Impact factor: 20.096
Authors: Stephen F Kappa; Elizabeth A Green; Nicole L Miller; Stanley D Herrell; Christopher R Mitchell; Hassan R Mir; Matthew J Resnick Journal: J Urol Date: 2016-04-27 Impact factor: 7.450
Authors: Danyon J Anderson; David Y Cao; Jessica Zhou; Matthew McDonald; Abrahim N Razzak; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits Journal: Health Psychol Res Date: 2022-09-15